{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:16:26Z","timestamp":1693008986406},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.genhosppsych.2009.05.005","type":"journal-article","created":{"date-parts":[[2009,6,24]],"date-time":"2009-06-24T10:18:09Z","timestamp":1245838689000},"page":"478-483","source":"Crossref","is-referenced-by-count":21,"title":["Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials"],"prefix":"10.1016","volume":"31","author":[{"given":"Beatriz","family":"Arbaizar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trinidad","family":"Dierssen-Sotos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"G\u00f3mez-Acebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2009.05.005_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0025-7125(05)70334-5","article-title":"Bipolar disorder","volume":"85","author":"Keck","year":"2001","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib2","series-title":"The American psychiatric publishing textbook of psychopharmacology","first-page":"865","article-title":"Treatment of bipolar disorder","author":"Keck","year":"2004"},{"issue":"suppl 1","key":"10.1016\/j.genhosppsych.2009.05.005_bib3","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0165-0327(00)00179-8","article-title":"Maintenance therapies for classic and other forms of bipolar disorder","volume":"59","author":"Bowden","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000091771","article-title":"Current status augmentation and combination treatments for major depressive disorder: a literature review and proposal for a novel approach to improve practice","volume":"75","author":"Fava","year":"2006","journal-title":"Psychoter Psychosom"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4088\/JCP.v68n0207","article-title":"A randomized, double-blind comparison of olanzapine\/fluoxetine combination, olanzapine and fluoxetine in treatment-resistant major depressive disorder","volume":"68","author":"Thase","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnoses and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4088\/PCC.v08n0205","article-title":"An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression","volume":"8","author":"Patkar","year":"2006","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib8","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.4088\/JCP.v66n1017","article-title":"Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder","volume":"66","author":"Papakostas","year":"2005","journal-title":"J Clin Psychyatry"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","article-title":"Aripiprazole monotherapy in non-psychotic bipolar I depression","volume":"28","author":"Thase","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J\u008aPharmacol Exp Ther"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-006-0621-y","article-title":"Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies","volume":"190","author":"Stark","year":"2007","journal-title":"Psychopharmacology(Berl)"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v68n0602","article-title":"Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis","volume":"68","author":"Papakostas","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.v68n0604","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study","volume":"68","author":"Berman","year":"2007","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/JCP.0b013e31816774f9","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder","volume":"28","author":"Marcus","year":"2008","journal-title":"J\u00a0Clin Psychopharmacology"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib15","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1586\/14737175.6.12.1777","article-title":"Role of aripiprazole in treating mood disorders","volume":"6","author":"Garcia-Amador","year":"2006","journal-title":"Expert Rev Neurotherapeutics"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"The CN138-135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"JwAffect Disord"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib19","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","article-title":"Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study","volume":"194","author":"Young","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2009.05.005_bib21","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","volume":"68","author":"Keck","year":"2007","journal-title":"J Clin Psychiatry"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834309000929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834309000929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T16:50:08Z","timestamp":1545151808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834309000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0163834309000929"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2009.05.005","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}